Author

David P. Adam

University of Wisconsin–MadisonORCID 0000-0002-8282-6660Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Aeli P. OlsoniD· 1 shared Amanda G. SheaiD· 1 shared Amber M. BatesiD· 1 shared Anatoly N. PinchukiD· 1 shared Bryan P. BednarziD· 1 shared C. de Aguiar FerreiraiD· 1 shared Caroline P. KerriD· 1 shared Christopher F. MasseyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aeli P. OlsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models

Caroline P. Kerr, Julia Sheehan‐Klenk, Joseph J. Grudzinski, David P. Adam, Thanh Phuong T. Nguyen, C. de Aguiar Ferreira, Amber M. Bates, Won Jong Jin, Ohyun Kwon, Aeli P. Olson, Wilson Lin, Meredith Hyun, Justin C. Jagodinsky, Maria Powers, Raghava N. Sriramaneni, , Zachary Scott Morris

This study examines how different radionuclides affect the type I interferon response in tumor models and shows that 225Ac enhances immunotherapy response via STING-dependent mechanisms.

Cancer Immunology Research · May 29, 2025Peer-reviewedCancer Biology